| Receptor . | Ligand . | Ligand type . | Protein Data Bank accession number . | Resolution (Å) . | Reference . |
|---|---|---|---|---|---|
| M1R-T4L | Tiotropium | Inverse agonist | 5CXV | 2.7 | Thal et al., 2016 |
| M2R-T4L | QNB | Inverse agonist | 3UON | 3.0 | Haga et al., 2012 |
| M2R•Nb9.8 | Iperoxo | Agonist | 4MQS | 3.5 | Kruse et al., 2013 |
| M2R•Nb9.8 | Iperoxo + LY2119620 | Agonist + PAM | 4MQT | 3.7 | Kruse et al., 2013 |
| M3R-T4L | Tiotropium | Inverse agonist | 4DAJ | 3.4 | Kruse et al., 2012 |
| M3R-dsT4L | Tiotropium | Inverse agonist | 4U14 | 3.6 | Thorsen et al., 2014 |
| M3R-mT4L | Tiotropium | Inverse agonist | 4U15 | 2.8 | Thorsen et al., 2014 |
| M3R-mT4L | NMS | Inverse agonist | 4U16 | 3.7 | Thorsen et al., 2014 |
| M4R-mT4L | Tiotropium | Inverse agonist | 5DSG | 2.6 | Thal et al., 2016 |
| Receptor . | Ligand . | Ligand type . | Protein Data Bank accession number . | Resolution (Å) . | Reference . |
|---|---|---|---|---|---|
| M1R-T4L | Tiotropium | Inverse agonist | 5CXV | 2.7 | Thal et al., 2016 |
| M2R-T4L | QNB | Inverse agonist | 3UON | 3.0 | Haga et al., 2012 |
| M2R•Nb9.8 | Iperoxo | Agonist | 4MQS | 3.5 | Kruse et al., 2013 |
| M2R•Nb9.8 | Iperoxo + LY2119620 | Agonist + PAM | 4MQT | 3.7 | Kruse et al., 2013 |
| M3R-T4L | Tiotropium | Inverse agonist | 4DAJ | 3.4 | Kruse et al., 2012 |
| M3R-dsT4L | Tiotropium | Inverse agonist | 4U14 | 3.6 | Thorsen et al., 2014 |
| M3R-mT4L | Tiotropium | Inverse agonist | 4U15 | 2.8 | Thorsen et al., 2014 |
| M3R-mT4L | NMS | Inverse agonist | 4U16 | 3.7 | Thorsen et al., 2014 |
| M4R-mT4L | Tiotropium | Inverse agonist | 5DSG | 2.6 | Thal et al., 2016 |